Clinical Trial Update: Dyslipidemia in Type 2 Diabetes (0767-034) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating dyslipidemia in adults with type 2 diabetes (NCT00547274) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type II, Dyslipidemia | Phase 3 | Status: TERMINATED